Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies.
Yang X, Li Y, Li Y, Ren X, Zhang X, Hu D, Gao Y, Xing Y, Shang H. · 2017
Read Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies. by Yang X, Li Y, Li Y, Ren X, Zhang X, Hu D, Gao Y, Xing Y, Shang H. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5572357.txt.
Introduction
Yang and co-authors review oxidative stress in atherosclerosis in Frontiers in Physiology. Atherosclerosis builds fatty plaques in artery walls. Plaque rupture can cause heart attack and stroke. Oxidative stress is widely seen as a core driver of plaque growth.
That stress arises when reactive oxygen species outrun the body's defenses. It can damage proteins, fats, and DNA in vessel cells. It can also trigger cell death signals. The review traces five routes that feed it: inflammation, mitochondria, autophagy, cell death, and epigenetic change. Treatments that fight oxidative stress are also covered. Readers get a broad map of one major theory of artery disease.
Catalog record
| CREATOR | Yang X, Li Y, Li Y, Ren X, Zhang X, Hu D, Gao Y, Xing Y, Shang H. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 90 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies By Xinyu Yang, Yang Li, Yanda Li, Xiaomeng Ren, Xiaoyu Zhang, Dan Hu, Yonghong Gao, Yanwei Xing, Hongcai Shang Published in: Frontiers in Physiology DOI: 10.3389/fphys.2017.00600 ABSTRACT Atherogenesis, the formation of atherosclerotic plaques, is a complex process that involves several mechanisms, including endothelial dysfunction, neovascularization, vascular proliferation, apoptosis, matrix degradation, inflammation, and thrombosis. The pathogenesis and progression of atherosclerosis are explained differently by different scholars. One of the most common theories is the destruction of well-balanced homeostatic mechanisms, which incurs the oxidative stress. And oxidative stress is widely regarded as the redox status realized when an imbalance exists between antioxidant capability and activity species including reactive oxygen (ROS), nitrogen (RNS) and halogen species, non-radical as well as free radical species. This occurrence results in cell injury due to direct oxidation of cellular protein, lipid, and DNA or via cell death signaling pathways responsible for accelerating atherogenesis. This paper discusses inflammation, mitochondria, autophagy, apoptosis, and epigenetics as they induce oxidative stress in atherosclerosis, as well as various treatments for antioxidative stress that may prevent atherosclerosis. INTRODUCTION Atherosclerosis, the formation of atherosclerotic plaques, remains a major reason of the morbidity and mortality in both developed and developing nations (Townsend et al., 2015). The World Health Organization redounds an estimated 16.7 million deaths to the atherosclerotic cardiovascular disease (Association, 2007; Leopold and Loscalzo, 2008). Atherosclerotic plaque rupture is a usual reason of the cardiovascular diseases, as stroke and myocardial infarction (Grootaert et al., 2015). Atherogenesis is a complicated course that concerns some mechanisms including endothelial dysfunction, neovascularization, vascular proliferation, apoptosis, matrix degradation, oxidative stress, inflammation, and thrombosis (Hansson, 2005). The pathophysiological mechanisms of atherosclerosis have yet to be illuminated, though most hypotheses about its pathogenesis and progression concern the disruption of normal homeostatic mechanisms incurring oxidative stress. Studies have shown that oxidative stress is a pivotal feature of the atherogenesis (Witztum and Berliner, 1998). It is widely defined as the redox status realized when an imbalance exists between antioxidant capability and activity species including reactive oxygen (ROS), nitrogen (RNS) and halogen species, non-radical as well as free radical species (Leopold and Loscalzo, 2009). These conditions cause cell injury by directly oxidizing cellular protein, lipid, and DNA or via cell death signaling pathways (Leopold and Loscalzo, 2009; Sinha et al., 2013). In the cell, ambient levels of certain ROS are used as signaling molecules to sustain fundamental cellulate functions. In comparison, reactivity oxidants and free radicals are produced in absence of the physiological stimulus, and then small molecule antioxidants are depleted or antioxidase systems are being overwhelmed (Leopold and Loscalzo, 2009). It triggers a net increase in the oxidative stress and biologically activated ROS. It not only plays a important part in pathology of the cardiovascular diseases, but also has physiological functions that may adjust cardiomyocytes (Santos et al., 2011). Atherosclerosis is considered as a complex process featured by the positive involvement of immune systems (Galkina and Ley, 2007; Weber et al., 2008; Libby et al., 2013). This study focuses on the method by which inflammation, mitochondria, autophagy, apoptosis, and epigenetics induce oxidative stress to accelerate atherosclerotic lesion formation. Several drug-based treatments for antioxidative stress are also discussed below. REACTIVE OXYGEN SPECIES (ROS)–PRODUCING SYSTEMS IN ATHEROSCLEROSIS ROS at medium concentrations play important signaling roles under various physiological conditions (Li et al., 2014; Förstermann et al., 2017). Excessive ROS production outpacing the usable antioxidant systems results in oxidant stress (Li et al., 2014). Several primary ROS-producing systems are present in blood vessel wall embracing xanthine oxidase (XO), uncoupled endothelial nitric oxide synthase (eNOS), enzymes of the mitochondrial respiratory chain, and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOXs) (Brandes and Kreuzer, 2004; Förstermann, 2008, 2010; Li et al., 2014; Xia et al., 2017). These oxidases, composing of two membrane-combined subunits and several cytoplasmic modulatory subunits, are multisubunit enzyme compoundes which produce superoxide from the molecular oxygen employing NADPH served as electron donor (Bedard and Krause, 2007; Cave, 2009; Drummond et al., 2011). Be contrary to Nox1 and Nox2, Nox4 only needs p22phox and liberates hydrogen peroxide rather than superoxide (Schröder et al., 2012). Three Nox isotypes are expressed in the blood vessel wall of mice with in the vascular smooth muscle cells (VSMC); and Nox2 (Görlach et al., 2000) and Nox4 (Ago et al., 2004; Xu et al., 2008) are primarily expressed in endotheliocytes. Recent a study had indicated that Nox enzymes play different roles in atherogenesis (Fulton and Barman, 2016). XO produces hydrogen peroxide and superoxide by employing molecular oxygen as an electron acceptor (Nishino et al., 2008; Nomura et al., 2014). The expression of endothelial XO are increased through proatherosclerotic stimuli like angiotensin II (Ang II) treatment (Landmesser et al., 2007) as well as oscillatory shear stress (McNally et al., 2003). Usually, mitochondrial oxidative phosphorylation generates physiological levels of superoxide which translates into hydrogen peroxide by the manganese-dependent superoxide dismutase (SOD2), as well as subsequently by the glutathione peroxidase 1 (GPx1) to water (Wang et al., 2014a; Phaniendra et al., 2015). Atherosclerosis in humans has been associated with mitochondrial oxidative stress (Corral-Debrinski et al., 1992). eNOS generates NO under certain physiological conditions and thus represents a crucial vasoprotective element for the endothelium (Li and Förstermann, 2000, 2009; Förstermann and Sessa, 2012; Li et al., 2014). Under pathological conditions linked to oxidative stress, however, eNOS may become dysfunctional (Förstermann, 2008; Li and Förstermann, 2013; Li et al., 2013; Figure 1). [Figure: Reactive oxygen species–producing systems in atherosclerosis. MIT oxidative, Mitochondrial oxidative; eNOS, endothelial nitric oxide synthase; O2 •-, superoxide; OX, xanthine oxidase; NO•, nitric oxide; HOCl, hypochlorite; H2O2, hydrogen peroxide; ONOO−, peroxynitrite; •OH, hydroxyl radicals; SOD, enzyme superoxide dismutase; GSH, glutathione; Trx, thioredoxin. O2•- can be generated in the blood vessel wall by NOXs, uncoupled eNOS, OX, and mitochondrial respiration chains. H2O2 can traverse spontaneous transformation to •OH by Fe reaction, SOD. H2O2 can be detoxified through GSH peroxidase, Trx peroxidase, and catalase to H2O and O2. Meanwhile, the myeloperoxidase enzyme can employ H2O2 to oxygenize chloride to the strong oxidizer HOCl. The uncoupling eNOS decreases endothelial NO production, which is further aggravated by reduced eNOS expression and activity.] MACROPHAGES INDUCE OXIDATIVE STRESS IN ATHEROSCLEROSIS Macrophages are diverse, bactericidal, and scavenging tissue-resident cells responsible for an array of crucial immune functions (Maiuri et al., 2013). Macrophages are the most numerous immune cell genre in the pathological changes of atherosclerotic, they are concerned from lesion initiation to plaque rupture, and play a requisite role through all stage of the disease (Cochain and Zernecke, 2017). These immune cells mainly consume poisonous blood fat, such as oxidized low-density lipoprotein (ox-LDL) as portion of their normal scavenging function. The lipid-laden macrophages are deposited underneath the endothelium of arteries, eventually forming obstructive atherosclerotic plaques. Recent studies have confirmed that macrophage cellular oxidation, 7-hydroperoxide (7-OOH), autophagy protein 5 (ATG5), and thiol oxidative stress enhances macrophage cellular oxidative stress and accelerates atherosclerotic plaque progression. Macrophage cellular oxidation and oxidative stress A recent study (Abu-Saleh et al., 2016) demonstrated that the components of atherosclerotic plaque enhance macrophage cellular oxidation. Macrophages from atherosclerotic normo- or hyper-glycemic apoE−/− mice were cultured with mouse aorta aqueous or lipid extract dated from these mice, while J774A.1-incubated macrophages were cultured with enhancing